In the quest to combat Alzheimer’s Disease, the discovery of TIM-3 as a crucial immune checkpoint molecule opens new avenues for innovative treatments.This research highlights how TIM-3 therapy can potentially bolster cognitive functions by allowing microglia to effectively target and clear amyloid plaques from the brain.